Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/enwGCfbwocfEAzzFFqfP

March 19, 2013News for medical technology professionals

  Top Story 
  • FDA OKs 2 HUD designations for artificial heart from SynCardia
    The FDA has granted SynCardia Systems humanitarian use device exemption approval for its 50cc Total Artificial Heart to be used as a bridge-to-transplant for pediatric patients and others with small stature. The device also received HUD approval as a destination therapy system for heart failure patients at risk of imminent death. MassDevice.com (Boston) (3/18) LinkedInFacebookTwitterEmail this Story
Devices are Healthcare's Hottest Commodity in '13
If Charles Dickens were alive today and wrote for Medical Device Daily he might be inclined to use his familiar opening line of "A Tale of Two Cities" to describe the current state of the med-tech industry: It was the best of times, it was the worst of times. Find out the details.

  Business & Market Trends 
Selling your business? Here are 7 things you should do now.
If you're considering selling your business, you should be doing everything you can to get the best possible price. In just 7 simple steps you can improve your chances of attracting buyers and getting big bucks for your business. Read the article and learn the 7 steps.

  International Developments 
 
eBook: Why It's Time to Evaluate Your Timekeeping System
Download the free eBook to learn why yesterday's timekeeping tools aren't cut out for today's rapidly evolving compliance mandates. Learn how modern, cloud-based solutions can help you reduce the risk of noncompliance, gain unprecedented visibility, and manage in the moment. Don't let outdated workforce management tools drag you down. Click here to learn more.

  Science & Health 
 
Combating Identity Theft in a Mobile, Social World
Mobile connectivity threats extend from consumers to the business environment. But who is really responsible for securing sensitive information? Smart business leaders are becoming proactive on the matter. Learn how to get protected in this white paper. Download the white paper now.

  Emerging Technologies 
 
  • 3D ear scanner from Lantos scores FDA clearance
    The FDA has cleared Lantos Technologies to market its 3D ear scanning device. The scanner, set to be released later this year, allows for the development of hearing aid devices that are customized to each patient by streamlining the way ear topology is measured, according to the company. Boston Herald (3/18) LinkedInFacebookTwitterEmail this Story
  • Salivary duct access devices from Cook Medical are available
    A set of salivary duct access tools has been released by Cook Medical through its new Otolaryngology—Head and Neck Surgery business unit. The products, which are used to remove occlusions in the salivary duct, include the Kolenda salivary access introducer set, the NGage and NCircle salivary stone extractors, a serial dilator set and a guide wire. MedGadget.com (3/18) LinkedInFacebookTwitterEmail this Story
Whitepaper: SDN: How do you get there from here?
Are the growing data needs of mobile, cloud, big data and social threatening today's enterprise networks? Scalable processes, a phased integration approach and the appetite to optimize over time are key components of a modern network. It's how agile organizations prepare for the data needs of tomorrow.
Explore the whitepaper to start down the path toward SDN.

  Government & Regulatory 
  • Proposed budget hike would increase FDA oversight in China
    A Senate bill that aims to raise the FDA's fiscal 2013 budget to $2.5 billion has gained support from the Alliance for a Stronger FDA, which calls it "strongly favorable" to the agency. The measure, which includes the new user fees for medical devices, drugs and biologics, provides $10 million to allow the agency to beef up its inspections in China, the group said. In-PharmaTechnologist.com (3/18) LinkedInFacebookTwitterEmail this Story
AdvaMed News 
  • Join the AdvaMed-MTLI LinkedIn group!
    Build close relationships with member companies, both small and large, and receive an intimate understanding of the key issues affecting innovation, access and the bottom line. Interact in discussions that leverage the leadership and expertise of the medical technology industry. This social group is full of key stakeholders, influencers and industry thought leaders as well as regulatory and policy experts from the FDA and CMS. Aside from practical learning opportunities, this LinkedIn group provides the premier opportunity to network with key players from virtually every aspect of the industry. Link to the AdvaMed MTLI LinkedIn group page. LinkedInFacebookTwitterEmail this Story
 
Learn more about AdvaMed ->About AdvaMed | Join | Courses | Events | Newsroom

 
Position TitleCompany NameLocation
Sales / Technical SpecialistKaneka Pharma America LLCNew York, NY
Sales Area Manager/Sales Rep of Neurovascular Intervention ProductsAsahi Intecc USA, Inc.Any location in US, CA
Sr.Regulatory Affaris AssociateMindray DS USA, Inc.Mahwah, NJ
Project Manager, Regulatory Affairs - Transfusion Medicine Johnson & JohnsonRaritan, NJ
Associate CounselACell, Inc.Columbia, MD
Compliance Consultant 2DJO GlobalVista, CA
Accreditation ManagerAmerican Association of Tissue BanksMcLean, VA
REGULATORY AFFAIRS SPECIALISTMasimo CorporationIrvine, CA
Director, Health Care ComplianceRTI BiologicsAlachua, FL
Manager, HCL Regulatory & Quality ComplianceOwens & MinorLouisville, KY
Click here to view more job listings.

  SmartQuote 
You may have to fight a battle more than once to win it."
--Margaret Thatcher,
British prime minister


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Meryl Harold (202) 407-7828
Job Board:  Jackie Basso (202) 407-7871
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AdvaMed SmartBrief Issues:   Lead Editor:  Lisa Gough
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information